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Comparative history of medicine
S U M M A R Y
Background: Malaria is still an active threat in many areas of the world. In Greece, in an area of the
Laconia region, malaria epidemics have been recorded since as early as the 5th century BC. A local
outbreak of malaria was reported in the summer/autumn of 2011.
Method: A comparative research study of historical and modern sources was carried out in order to
explore the malaria outbreaks occurring in the area of Laconia, Greece.
Results: The study revealed that the central area (Elos and Skala), the peak season (early autumn), the
Plasmodium species (P. vivax), the mosquito vector (Anopheles sacharovi), and the risk factors (wetlands
and population movements) have, more or less, remained unchanged throughout the 2500-year span in
Laconia.
Conclusions: Unique regional features preserve a seemingly recurring pattern of malaria outbreaks in
this area of Greece. This study, based on low-cost effective research, offers a clear public health message.
The Greek authorities responsible for health policy could build upon these ﬁndings in order to achieve
the desired eradication.
 2012 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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1. Introduction
Although the history of malaria predates humanity, our
understanding of its causative agents begins in 1880, when
Charles Louis Alphonse Laveran was the ﬁrst to discover protozoan
parasites in the blood of affected patients.1 The Plasmodium genus
currently comprises at least 172 named species, infecting a wide
range of mammals, birds, reptiles, and amphibians. P. falciparum, P.
vivax, P. ovale, P. malariae, and P. knowlesi are implicated in human
malaria, with female Anopheles mosquitoes being their exclusive
transmission vectors.2 P. falciparum, associated with acute, highly
complicated and often fatal disease, is the predominant species,
accounting for 92% of malaria cases globally.3 On the other hand, P.
vivax, extending well beyond the tropics, accounts for almost
half of the malaria cases outside of Africa, with up to 390
million clinical infections per year. The species is traditionally
thought to cause benign, possibly relapsing disease, although* Corresponding author. Tel.: +44 7568327535.
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malaria as a rare and fastidious killer.4 P. malariae, P. ovale, and P.
knowlesi have a limited distribution worldwide.5,6
Despite the ongoing application of extensive control measures
on a global scale, malaria remains the most signiﬁcant parasitic
infection in humans, claiming over a million lives annually.3
Factors contributing to the resurgence of the disease in modern
times include population movements within or through endemic
countries, the spread of chloroquine resistance among malaria
parasites, and the emergence of insecticide-resistant mosquitoes.7
In this context, Greece reported 36 cases of P. vivax malaria
infection in 2011 (as of September 27), the vast majority of which
(30 cases) were associated with the Evrotas area of Laconia district
(mostly localized in the plain of Elos, Skala village, Figure 1),
located in the Peloponnese region of southern Greece. Anopheles
sacharovi has been recognized as the dominant vector in this
region. Among those 30 cases, 14 were in Greek citizens who had
no history of travel to an endemic country, and 16 were in migrant
workers mainly from Pakistan, with an undetermined importation
status. Anti-malaria therapy was successful in all patients, with the
exception of one fatality in an elderly male who had signiﬁcant
comorbidities.8
It is well known that Laconia is an area where epidemics, or
occasionally high incidences, of malaria have been systematically
recorded in the past, and it would be interesting to exploreses. Published by Elsevier Ltd. All rights reserved.
Figure 1. Map of Laconia and the Evrotas municipality, indicating the position of the
most important sites for malaria.
Figure 2. The plain of Elos in Laconia, Greece. Wetlands and marshes are clearly
visible (photo courtesy of Antonis A. Kousoulis; May 15, 2011).
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features throughout the centuries. Thus, the objective of the
current study was to elucidate the patterns of malaria outbreaks in
this province in order to suggest policy interventions to effectively
eradicate the disease.
2. Methods
A comparative research of historical and modern sources was
undertaken in order to explore the malaria outbreaks in the area of
Laconia, Greece. The authors put extra effort into uncovering
relevant primary sources. We suggest this model of research as
quite effective in resource-limited settings, like modern Greece,
since it constitutes a low-cost way to trace signiﬁcant evidence in
order to aid health policy measures.
3. Results
3.1. 5th Century BC
Hippocrates frequently referred to a burning disease. This is the
fever he mentioned more than any other in his writings, thus we
can reasonably assume that the disease was unusually prevalent
during his times.9 He also recorded a feverish disease epidemic
attributed to factors emanating from marshes.10 It has been
suggested that these infections (which occurred acutely, had
remissions, and were occasionally fatal)11 are to be identiﬁed with
remittent or sub-continuous malarial fever.10,12,13 The confusing
part of this assumption is that while malaria in the Mediterranean
is a summer disease, Hippocrates clearly asserted that this fever
occasionally occurred in the autumn and winter.10,11 The true
explanation for this lies most probably in the fact that the malaria
season (when malaria was endemic) differed across Greece; it has
been recorded that in the area of Sparta, epidemics occurred from
mid-September to November.14According to historical sources it seems probable that malaria
spread severely in Greece around the 5th century BC. Torrents and
gorges were common enough and, by partially drying up in the
summer, would form little pools. Many lowlands became marshes
after heavy rain. Notably, in Laconia, there is a plain named Elos,
meaning swamp, exactly because the surrounding area (remark-
ably close to the 2011 epidemic) has many swamps and marshes
(Figure 2). Interestingly, the Greek word for malaria, elonosia,
stems from the very same word (elos + nosos, thus the disease of the
marsh). Therefore, when the number of malaria patients coming in
from abroad increased, as they certainly did during the frequent
warfare of the time, malaria epidemics were a certainty. And after
these epidemics, the country offered the perfect preconditions for
the disease to become endemic.10,15
P. vivax may well have been the cause of early malaria
epidemics in Greece, since paleopathological evidence shows that
it diverged approximately two million years ago from a group of
parasites endemic in apes,16 and coevolved with humankind in the
Mediterranean countries.17,18 From Hippocrates’ descriptions of
the clinical features of the probable malaria epidemics, it appears
that either P. vivax or P. malariae must have been the predominant
pathogen.13
3.2. Early 20th century
The Greek Anti-Malaria League, following the model of similar
institutions in Italy, was founded in 1905. Its ﬁrst work was to
estimate the prevalence of the disease throughout the country.
Shortly after the forming of this association, a severe malaria
epidemic, peaking in late August–September, occurred in
Greece.19 Data from areas around Laconia in 1905 reveal the
severity: about 20% of the inhabitants of today’s Evrotas
municipality had the disease, 3–5% in the highlands and 100%
in the plain of Elos. In nearby areas 2–10% of the inhabitants were
patients in Gythion, 5–15% in Oitylo, 10–50% around the village of
Elaia, a small number in Kythira, but 40–60% in one of its districts.
All in all, it was calculated that out of a total population of
2 433 806 studied, no fewer than 960 048 were attacked by
malaria and 5916 died.14
The pathogen and the vector causing that epidemic, which was
more severe in the plain of Elos in Laconia, are uncertain. However,
the low mortality may imply infection with P. vivax. Historically,
we cannot be sure of the Anopheles species responsible for previous
malaria epidemics in Greece. However, it is notable that A.
sacharovi has been systematically observed in Laconia since the
1940s, thus we could reasonably assume that it is a species residing
in Laconia, perhaps responsible for historical epidemics.20
Table 1
Common characteristics of historical and current major malaria outbreaks in Laconia, Greece
Signiﬁcant malaria outbreaks in Laconia, Greece
5th century BC Early 20th century Mid 20th century 2011
Main areas Plain of Elos Plain of Elos Plain of Elos Plain of Elos
Season Mid-September–November August–September August–September August–October
Recorded risk factors Marshes, population movement due to
warfare





Species Plasmodium vivax, or Plasmodium malariae Uncertain (low mortality
may imply Plasmodium vivax)
Plasmodium vivax Plasmodium vivax
Dominant vector Mosquitoes described, hard to identify Uncertain Anopheles sacharovi Anopheles sacharovi
(Historically Anopheles sacharovi seemingly
dominant in the plain of Elos)
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aid of the Nobel laureate Sir Ronald Ross,21 took many measures to
ﬁght malaria in the early 20th century. It ranked as its foremost
action the education, through lectures, circulars, and public notices,
of both the public and physicians on malaria and new discoveries
concerning this disease. In order to successfully ﬁght malaria, a
combination of two measures was suggested: (1) the draining of the
marshes or the extermination of the Anopheles mosquitoes, and (2)
the killing, by quinine, of the parasites in the blood of the infected.14
However, drying up the marshes around the large Greek lakes was
subject to engineering difﬁculties, and there were problems with the
distribution of pure quinine, which could not reach the poor safely.
Moreover, it is now well known that only primaquine eradicates the
hypnozoite form of the parasite from the liver, from where relapses
of the disease can occur.
3.3. Mid 20th century
A new project against malaria was initiated in the mid 20th
century, in particular during the 1940s and 1950s, following the
introduction of the insecticide DDT (dichlorodiphenyltrichlor-
oethane). Supported by valuable data from geographical and
entomological surveys, the abundance of DDT for air-spraying, and
the work of Gregory Livadas at the School of Hygiene, the project
had many advantages. Centralized control, research on the
common vectors, members of the Royal Hellenic Air Force piloting
air-spraying airplanes, and extended house spraying were the ﬁrst
steps.22
Regarding the local outbreaks occurring in Laconia around
these years (a period of huge intra-country migration), Elos and
Skala were the center, resistant A. sacharovi was the usual vector,
and the malarial species involved was P. vivax.20,22,23
4. Discussion
The study and comparison of historical data bring to light a
potentially recurring pattern in the malaria outbreaks occurring in
the district of Laconia. As vividly revealed in Table 1, all the
epidemics in this district were mainly localized to the plain of Elos,
tending to peak in the early autumn. To a great extent they can be
attributed to some population movement and to the area wetlands,
which preserve the potentiality for new outbreaks. Moreover,
taking into account clinical features and historical studies, we can
reasonably assume (in some cases with less certainty) that these
epidemics are normally associated with the pathogen species P.
vivax and the mosquito vector A. sacharovi.
All these features were seen in the most recent epidemic in
2011. Particular characteristics of the area of interest include a
large inﬂux of migrants from malaria endemic countries occurring
in recent years. Furthermore, this area is nowadays characterized
by freshwater springs, a complex network of 130 km of irrigationand drainage channels, the Evrotas river delta, the brackish Vivari
lake, which seasonally dries out, and the coastal wetlands that
form part of a nature reserve within the Nature 2000 Network.8
Over and above this, studies from Greece have shown some
correlation between DDT and Dieldrin resistance, but a clear
double-resistance has been found only in Skala, thus indicating an
excessive use of insecticides.24
There appears to be a lack of signiﬁcant references on malaria
epidemics in Laconia in the time window between the 5th century
BC and the 20th century AD. However, in the 1st century AD, it is
certain that Greeks were familiar at least with the features of a
disease resembling malaria. Through the writings of eminent
physician Aretaeus of Cappadocia, it is plain enough that he lived
when malaria was universal and, in some places, severe. He
convincingly cited the unhealthiness of autumn and the evening
time, undoubtedly referring to the season of the year and the time
of the day when mosquitoes are most dangerous.25 In another
passage he wrote that marshy districts are always unhealthy and in
summer pestilential. Interestingly enough, physician Agathinus
from Laconia wrote a special treatise on semi-tertian fevers,
proving the continuing endemicity of the disease in the area.26
In conclusion, our comparison offers a clear public health
message, since the lessons of the past, implemented in the present,
point to speciﬁc directions regarding the responsible factors for the
repeating malaria epidemics, also indicating how low-cost
research (much needed in the current resource-limited Greek
environment) may aid policy interventions. For example, active
case ﬁnding and residual indoor spraying has been proposed
among the main measures to control this local outbreak, and since
April 2012 an integrated mosquito control program has been
conducted by the municipality of Evrotas.27
Unique regional features seem to have preserved a recurring
pattern of malaria outbreaks in Laconia, Greece, for 2500 years. In
order to support its claims of eradication, even in areas where
malaria is traditionally highly prevalent, the Greek public health
authorities could build upon these ﬁndings.
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